TAG Heuer cuts ties with tennis player Maria Sharapova

The move was made after the player earlier confessed about failing a drug test.

"Maria Sharapova was under contract with TAG Heuer until December 31th, 2015. We had been in talks to extend our collaboration. In view of the current situation, the Swiss watch brand has suspended negociations,"  a TAG Heuer Spokeperson told IBNS by e-mail.

Sharapova ran into deeper trouble as Nike pulled off their deal post her confession about failing a drug test.

In a shocking revelation, Sharapova on Monday said she failed a drugs test at the Australian Open.

She tested positive for meldonium and has been provisionally banned from the sport. Her ban will come into effect from Mar 12.

Her yearly merchandise, estimated at USD 30 Million is likely to take a hit.

The former world number one said during a press conference: "I made a huge mistake."

The International Tennis Federation (ITF) website said on Jan  26, 2016, Sharapova provided an anti-doping sample to the TADP in association with her participation in the 2016 Australian Open.

That sample was analysed by a World Anti-Doping Agency (WADA) accredited laboratory, which returned a positive for meldonium, which is a prohibited substance under the WADA Code and, therefore also the TADP.

In accordance with Article 8.1.1 of the TADP, Sharapova was charged on Mar 2 with an Anti-Doping Rule Violation.

Sharapova has accepted the finding of meldonium in her sample collected on Jan 26.

As meldonium is a non-specified substance under the WADA (and, therefore, TADP) list of Prohibited Substances and Prohibited Methods, the ITF said.

Sharapova said: "I did fail the test and take full responsibility for it."

She said: "For the past 10 years I have been given a medicine called mildronate by my family doctor."

"Few days ago, after I received a letter from the ITF, I found out it also has another name of meldonium. I did not know," she said.

Image: Wikimedia Commons